{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:15:31Z","timestamp":1792610131253,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T00:00:00Z","timestamp":1557100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00520-019-04841-x","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T16:27:29Z","timestamp":1557160049000},"page":"395-403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of protocol change on individual factors related to course of adverse reactions to chemotherapy for breast cancer"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0576-7361","authenticated-orcid":false,"given":"Daniela Polessa","family":"Paula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa I.","family":"do Brasil Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosane V.","family":"Jorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio F.","family":"Nobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,6]]},"reference":[{"issue":"1","key":"4841_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1200\/JCO.2007.11.3787","volume":"26","author":"M De Laurentiis","year":"2008","unstructured":"De Laurentiis M, Cancello G, D'Agostino D, Giuliano M, Giordano A, Montagna E et al (2008) Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials. J Clin Oncol 26(1):44\u201353. https:\/\/doi.org\/10.1200\/JCO.2007.11.3787","journal-title":"J Clin Oncol"},{"key":"4841_CR2","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3892\/or-00000963","volume":"24","author":"MSU Hassan","year":"2010","unstructured":"Hassan MSU, Ansari J, Spooner D, Hussain SA (2010) Chemotherapy for breast cancer (review). Oncol Rep 24:1121\u20131231. https:\/\/doi.org\/10.3892\/or-00000963","journal-title":"Oncol Rep"},{"key":"4841_CR3","unstructured":"Solimando DA (2003). Drug information handbook for oncology: featuring a complete guide to combination chemotherapy regimens. Lexi-comp"},{"key":"4841_CR4","unstructured":"Chu E, DeVita VT Jr (2017). Physicians' Cancer Chemotherapy Drug Manual 2018. Jones & Bartlett Learning"},{"issue":"1","key":"4841_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/157488607779315507","volume":"2","author":"EC Davies","year":"2007","unstructured":"Davies EC, Green CF, Mottram DR, Pirmohamed M (2007) Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf 2(1):79\u201387. https:\/\/doi.org\/10.2174\/157488607779315507","journal-title":"Curr Drug Saf"},{"issue":"10","key":"4841_CR6","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/SMJ.0b013e3181f0c866","volume":"103","author":"JM Wooten","year":"2010","unstructured":"Wooten JM (2010) Adverse drug reactions: part I. South Med J 103(10):1025\u20131028. https:\/\/doi.org\/10.1097\/SMJ.0b013e3181f0c866","journal-title":"South Med J"},{"issue":"16","key":"4841_CR7","first-page":"71","volume":"7","author":"SZ Menon","year":"2005","unstructured":"Menon SZ, Lima AC, Chorilli M, Franco YO (2005) Rea\u00e7\u00f5es adversas a medicamentos (RAMs). Sa\u00fade Rev 7(16):71\u201379","journal-title":"Sa\u00fade Rev"},{"key":"4841_CR8","unstructured":"Larini L (2009). F\u00e1rmacos e medicamentos. Artmed Editora"},{"issue":"4","key":"4841_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2223\/1198","volume":"80","author":"AT Nagao-Dias","year":"2004","unstructured":"Nagao-Dias AT, Barros-Nunes P, Coelho HL, Sol\u00e9 D (2004) Rea\u00e7\u00f5es al\u00e9rgicas a medicamentos. J Pediatr 80(4):259\u2013266. https:\/\/doi.org\/10.2223\/1198","journal-title":"J Pediatr"},{"key":"4841_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/00002820-200208000-00004","volume":"25","author":"N De-Jong","year":"2002","unstructured":"De-Jong N, Courtens AM, Abu-Saad HH et al (2002) Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature. Cancer Nurs 25:283\u2013297. https:\/\/doi.org\/10.1097\/00002820-200208000-00004","journal-title":"Cancer Nurs"},{"issue":"24","key":"4841_CR11","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.1002\/cncr.25294","volume":"116","author":"MA Andrykowski","year":"2010","unstructured":"Andrykowski MA, Donovan KA, Laronga C, Jacobsen PB (2010) Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors. Cancer 116(24):5740\u20135748. https:\/\/doi.org\/10.1002\/cncr.25294","journal-title":"Cancer"},{"issue":"4","key":"4841_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1037\/0278-6133.26.4.464","volume":"26","author":"KA Donovan","year":"2007","unstructured":"Donovan KA, Small BJ, Andrykowski MA, Munster P, Jacobsen PB (2007) Utility of a cognitive-behavioral model to predict fatigue following breast cancer treatment. Health Psychol 26(4):464\u2013472. https:\/\/doi.org\/10.1037\/0278-6133.26.4.464","journal-title":"Health Psychol"},{"issue":"13","key":"4841_CR13","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1002\/cncr.28016","volume":"119","author":"LD Castel","year":"2013","unstructured":"Castel LD, Hartmann KE, Mayer IA, Saville BR, Alvarez J, Boomershine CS, Abramson VG, Chakravarthy AB, Friedman DL, Cella DF (2013) Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort. Cancer 119(13):2375\u20132382. https:\/\/doi.org\/10.1002\/cncr.28016","journal-title":"Cancer"},{"key":"4841_CR14","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/S1098-3597(06)80054-2","volume":"8","author":"GH Lyman","year":"2006","unstructured":"Lyman GH (2006) Risks and consequences of chemotherapy-induced neutropenia. Clin Cornerstone 8:S12\u2013S18. https:\/\/doi.org\/10.1016\/S1098-3597(06)80054-2","journal-title":"Clin Cornerstone"},{"key":"4841_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/1097-0142(19950101)75:1<11::AID-CNCR2820750104>3.0.CO;2-N","volume":"75","author":"BN Stein","year":"1995","unstructured":"Stein BN, Petrelli NJ, Douglass HO, Driscoll DL, Arcangeli G, Meropol NJ (1995) Age and sex are independent predictors of 5fluorouracil toxicity. Analysis of a large scale phase I trial. Cancer 75:11\u201317. https:\/\/doi.org\/10.1002\/1097-0142(19950101)75:1<11::AID-CNCR2820750104>3.0.CO;2-N","journal-title":"Cancer"},{"issue":"6","key":"4841_CR16","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1368-8375(98)00068-2","volume":"34","author":"GM McCarthy","year":"1998","unstructured":"McCarthy GM, Awde JD, Ghandi H, Vincent M, Kocha WI (1998) Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol 34(6):484\u2013490. https:\/\/doi.org\/10.1016\/S1368-8375(98)00068-2","journal-title":"Oral Oncol"},{"issue":"2","key":"4841_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3760\/cma.j.issn.0366-6999.2011.02.008","volume":"124","author":"BL Zhang","year":"2011","unstructured":"Zhang BL, Tong S, Zhang BN, Zheng S, Ning L\u00dc, Xu BH et al (2011) Polymorphisms ofgstp1is associated with differences of chemotherapy response and toxicity in breast cancer. Chin Med J 124(2):199\u2013204. https:\/\/doi.org\/10.3760\/cma.j.issn.0366-6999.2011.02.008","journal-title":"Chin Med J"},{"key":"4841_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cca.2009.03.038","volume":"404","author":"SM Tsai","year":"2009","unstructured":"Tsai SM, Lin CY, Wu SH, Hou LA, Ma H, Tsai LY, Hou MF (2009) Side effects after docetaxel treatment in Taiwanese breast cancer patients with CYP3A4, CYP3A5, and ABCB1 gene polymorphisms. Clin Chim Acta 404:160\u2013165. https:\/\/doi.org\/10.1016\/j.cca.2009.03.038","journal-title":"Clin Chim Acta"},{"issue":"3","key":"4841_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/leu.2008.323","volume":"23","author":"PR RochaV","year":"2009","unstructured":"RochaV PR, Fernandes JF, Filion A, Bittencourt H, Silva W Jr et al (2009) Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia. Leukemia 23(3):545\u2013556. https:\/\/doi.org\/10.1038\/leu.2008.323","journal-title":"Leukemia"},{"issue":"2","key":"4841_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.dmpk.2014.09.009","volume":"30","author":"M Ikeda","year":"2015","unstructured":"Ikeda M, Tsuji D, Yamamoto K, Kim YI, Daimon T, Iwabe Y, Hatori M, Makuta R, Hayashi H, Inoue K, Nakamichi H, Shiokawa M, Itoh K (2015) Relationship between ABCB1 gene polymorphisms and severe neutropenia in patients with breast cancer treated with doxorubicin\/cyclophosphamide chemotherapy. Drug Metab Pharmacokinet 30(2):149\u2013153. https:\/\/doi.org\/10.1016\/j.dmpk.2014.09.009","journal-title":"Drug Metab Pharmacokinet"},{"issue":"2","key":"4841_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1590\/S1415-790X2012000200002","volume":"15","author":"ES Aguiar","year":"2012","unstructured":"Aguiar ES, Giacomazzi JS, Aishameriane V, Bock H, Saraiva ML, Schuler L, Duarte D, Santos P, Almeida GR, Cale M, Camey SA, Ashton PP (2012) GSTM1, GSTT1, and GSTP1 polymorphisms, breast cancer risk factors and mammographic density in women submitted to breast cancer screening. Rev Bras Epidemiol 15(2):246\u2013255. https:\/\/doi.org\/10.1590\/S1415-790X2012000200002","journal-title":"Rev Bras Epidemiol"},{"issue":"2\u20133","key":"4841_CR22","first-page":"273","volume":"38","author":"JJ Linhares","year":"2005","unstructured":"Linhares JJ, Da Silva G, Cotrim ID, Nogueira de Souza NC, Coelho Noronha E et al (2005) Genetic polymorphism of GSTM1 in women with breast cancer and interact with reproductive history and several clinical pathologies. Biol Res 38(2\u20133):273\u2013281","journal-title":"Biol Res"},{"key":"4841_CR23","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2307\/2531734","volume":"44","author":"SL Zeger","year":"1988","unstructured":"Zeger SL, Liang KY, Albert PS (1988) Models for longitudinal data: a generalized estimating equation approach. Biometrics 44:1049\u20131060. https:\/\/doi.org\/10.2307\/2531734","journal-title":"Biometrics"},{"key":"4841_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2307\/2531248","volume":"42","author":"SL Zeger","year":"1986","unstructured":"Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121\u2013130. https:\/\/doi.org\/10.2307\/2531248","journal-title":"Biometrics"},{"key":"4841_CR25","doi-asserted-by":"publisher","unstructured":"Chu E, DeVita VT Jr (2009) Physicians\u2019 cancer chemotherapy drug manual 2018. Jones & Bartlett Learning. https:\/\/doi.org\/10.3779\/j.issn.1009-3419.2009.11.10","DOI":"10.3779\/j.issn.1009-3419.2009.11.10"},{"issue":"10","key":"4841_CR26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.32635\/2176-9745.RBC.2002v48n1.2266","volume":"48","author":"ED Saad","year":"2002","unstructured":"Saad ED, Hoff PM, Carnel\u00f3s RP, Katz A, Novis YA, Pietrocola M et al (2002) Crit\u00e9rios comuns de toxicidade do Instituto Nacional de C\u00e2ncer dos Estados Unidos. Rev Bras Cancerol 48(10):63\u201396","journal-title":"Rev Bras Cancerol"},{"issue":"3","key":"4841_CR27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"13","author":"A Trotti","year":"2003","unstructured":"Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V et al (2003) CTCAE v3. 0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13(3):176\u2013181 WB Saunders","journal-title":"Semin Radiat Oncol"},{"key":"4841_CR28","doi-asserted-by":"crossref","unstructured":"Diggle P, Diggle PJ, Heagerty P, Heagerty PJ, Liang KY, Zeger S (2002) Analysis of longitudinal data. Oxford University Press","DOI":"10.1093\/oso\/9780198524847.001.0001"},{"key":"4841_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","volume":"73","author":"KY Liang","year":"1986","unstructured":"Liang KY, Zeger SL (1986) Longitudinal data analysis using generalized linear models. Biometrika. 73:13\u201322. https:\/\/doi.org\/10.1093\/biomet\/73.1.13","journal-title":"Biometrika."},{"issue":"4","key":"4841_CR30","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/sim.3489","volume":"28","author":"LY Hin","year":"2009","unstructured":"Hin LY, Wang YG (2009) Working-correlation-structure identification in generalized estimating equations. Stat Med 28(4):642\u2013658. https:\/\/doi.org\/10.1002\/sim.3489","journal-title":"Stat Med"},{"issue":"7","key":"4841_CR31","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.csda.2010.02.013","volume":"54","author":"KC Lin","year":"2010","unstructured":"Lin KC (2010) Goodness-of-fit tests for modeling longitudinal ordinal data. Comput Stat Data Anal 54(7):1872\u20131880. https:\/\/doi.org\/10.1016\/j.csda.2010.02.013","journal-title":"Comput Stat Data Anal"},{"issue":"5","key":"4841_CR32","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1634\/theoncologist.9-5-538","volume":"9","author":"JD Hainsworth","year":"2004","unstructured":"Hainsworth JD (2004) Practical aspects of weekly docetaxel administration schedules. Oncologist 9(5):538\u2013545. https:\/\/doi.org\/10.1634\/theoncologist.9-5-538","journal-title":"Oncologist"},{"key":"4841_CR33","doi-asserted-by":"crossref","unstructured":"Burstein HJ. (2009). Personalized medicine and breast cancer care. Personalized Medicine and Breast Cancer Care","DOI":"10.6004\/jnccn.2009.0010"},{"key":"4841_CR34","first-page":"39","volume":"9","author":"C Seguin","year":"2017","unstructured":"Seguin C, Kovacevich N, Voutsadakis IA (2017) Docetaxel-associated myalgia\u2013arthralgia syndrome in patients with breast cancer. Breast Cancer: Targets Ther 9:39","journal-title":"Breast Cancer: Targets Ther"},{"issue":"3","key":"4841_CR35","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/annonc\/mdi095","volume":"16","author":"N De Jong","year":"2005","unstructured":"De Jong N, Candel MJJM, Schouten HC, Huijer Abu-Saad H, Courtens AM (2005) Course of mental fatigue and motivation in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol 16(3):372\u2013382. https:\/\/doi.org\/10.1093\/annonc\/mdi095","journal-title":"Ann Oncol"},{"key":"4841_CR36","first-page":"206","volume-title":"Categorical data analysis","author":"A Agresti","year":"2011","unstructured":"Agresti A, Kateri M (2011) Categorical data analysis. Springer, Berlin Heidelberg, pp 206\u2013208"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-04841-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-019-04841-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-04841-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T17:01:39Z","timestamp":1721235699000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-019-04841-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,6]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["4841"],"URL":"https:\/\/doi.org\/10.1007\/s00520-019-04841-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,6]]},"assertion":[{"value":"8 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The INCA Ethics Research Committee approved the study protocol (number 129\/08), and all subjects signed the informed consent form before inclusion in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}